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ABSTRACT
Introduction: Transient ischaemic attacks (TIAs) and
strokes are highly prevalent conditions. Stroke killed
5.7 million people worldwide in 2005 and is estimated
to cause 6.5 million deaths globally in 2015. Stroke
survivors are often left with considerable disability.
Many strokes are preceded by a TIA/‘minor’ stroke in
the previous 90 days and therefore the immediate
period after a TIA/minor’ stroke is a crucial time to
intervene to tackle known vascular risk factors.
Although rehabilitation following a TIA/minor stroke is
widely recommended, there is a paucity of research
that offers an evidence base on which the development
or optimisation of interventions can be based,
particularly for home-based approaches and non-
pharmacological interventions in the acute period
following the initial TIA/‘minor’ stroke. This systematic
review will investigate the effect of rehabilitation
programmes initiated within 90 days of the diagnosis
of a TIA or ‘minor’ stroke aimed at reducing the
subsequent risk of stroke.
Methods/design: This systematic review will be
reported in line with the Preferred Reporting Items
for Systematic Reviews and Meta-analyses(PRISMA)
guidance. Randomised and quasi-randomised
controlled trials of rehabilitation programmes
initiated within 90 days of a TIA or ‘minor’ stroke will
be included. Articles will be identified through a
comprehensive search of the following databases,
guided by a medical librarian: the Cochrane Library,
Web of Science, MEDLINE, Embase, CINAHL and
PsycINFO. Two review authors will independently
screen articles retrieved from the search for
eligibility and extract relevant data on
methodological issues. A narrative synthesis will be
completed when there is insufficient data to permit a
formal meta-analysis.
Discussion: This review will be of value to
clinicians and healthcare professionals working in
TIA and stroke services as well as to general
practitioners/family physicians who care for these
patients in the community and to researchers
involved in designing and evaluating rehabilitation
interventions.
Trial registration number: CRD42015016450.
BACKGROUND
Stroke prevalence, impact and risk
Stroke killed 5.7 million people worldwide in
2005 and is estimated to cause 6.5 million
deaths in 2015,1 with stroke survivors often
being left with considerable disability.2 Many
strokes are preceded by transient ischaemic
attacks (TIAs) in the previous 90 days,3 and
therefore the immediate period after a TIA
is a crucial time to intervene to tackle the
known vascular risk factors and reduce the
risk of stroke. In 2006, approximately 1700
TIAs and 4000 strokes occurred in Northern
Ireland alone.4
The 90-day risk of vascular events following
a TIA or ‘minor’ stroke, excluding events
within the ﬁrst week after diagnosis when the
risk is highest, can be as high as 18%.5 The
ABCD2 score (consisting of age, blood pres-
sure, clinical symptoms, duration of symp-
toms and presence of diabetes) in patients
with TIA is used to identify the future risk of
stroke.3 The presence of a new infarct, iden-
tiﬁed on brain imaging and indicating that
the patient has actually had a stroke rather
than a TIA, places the patient at higher risk
of a further stroke within the ﬁrst 90 days.6
Secondary prevention reduces risk of second
stroke
Immediate assessment of TIA and ‘minor’
stroke patients following the initial event,
with initiation within 24 h of secondary pre-
vention to tackle the known vascular risk
factors, focused on pharmacological inter-
ventions, can reduce the 90-day risk of stroke
to 2% within the research setting.7 Current
guidelines however, recommend that patients
should be assessed up to 1 week following a
potential diagnosis,8 rather than within
24 h.7 Evidence is growing regarding the con-
tribution of change in modiﬁable vascular
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risk factors to reductions in cardiovascular deaths and
there is a need to consider how to promote non-
pharmacological measures within secondary prevention.
Underlying pathological mechanism and risk factors for
TIA/’minor’ stroke
TIA and strokes are most commonly caused by the
embolic or thrombotic consequences of atherothrombo-
tic disease,9 which is similar to the underlying patho-
logical mechanism for cardiovascular disease (CVD).10–12
As well as sharing a similar underlying pathological mech-
anism, cerebrovascular and CVD share common under-
lying risk factors11 13 and there is a high prevalence of
asymptomatic coronary artery disease post-TIA.5 12 13–15
The modiﬁable risk factors for all vascular diseases
include smoking, excessive alcohol intake, physical
inactivity, dietary factors, hypertension, dyslipidaemia,
diabetes and obesity16 as well as low VO2max.
17–20 Five
modiﬁable risk factors are reported to account for 82%
of strokes: hypertension, smoking, obesity, unhealthy
diet and physical inactivity.21 Despite improvements in
acute stroke care, prevention remains the cornerstone of
reducing the stroke disease burden.22
Why is it important to do this review?
Although rehabilitation and secondary prevention pro-
grammes following an initial TIA or ‘minor’ stroke are
theoretically well-evidenced,23 24 there is a paucity of
well-informed rehabilitation programmes for clinicians
and healthcare professionals to use within this acute
period, particularly within the setting of the patient’s
home. This systematic review will help produce an evi-
dence base on which rehabilitation interventions can be
developed for this patient group, particularly within the
acute period following the diagnosis of TIA or ‘minor’
stroke, including optimal pharmacology and non-
pharmacological secondary vascular prevention.
AIM
This systematic review will investigate the effect of
rehabilitation programmes initiated within 90 days of a
TIA or ‘minor’ stroke aimed at reducing the subsequent
risk of stroke and speciﬁc vascular risk factors in adults.
Key objectives
The key objectives of this study are to:
1. Determine the effect of rehabilitation programmes
which have been initiated within 90 days of a patient
having a TIA or ‘minor’ stroke, in terms of addres-
sing the known vascular risk factors.
2. Determine the effect of rehabilitation programmes
which have been initiated within 90 days of a patient
having a TIA or ‘minor’ stroke, in terms of reduced
risk of subsequent stroke.
3. Determine if particular techniques or components of
programmes are associated with greater effect sizes.
METHODS/DESIGN
This review will be reported as per PRISMA guidelines
(see online supplementary ﬁle 1). Criteria for consider-
ing studies for this review will include the below.
Types of studies
All human randomised and quasi-randomised controlled
trials, published and unpublished, aimed at initiating
rehabilitation programmes within 90 days of patients suf-
fering a TIA or minor stroke.
Types of participants
The review will focus on adults aged 18 years or older,
who have received a diagnosis of a TIA and/or ‘minor’
stroke, based on a clinical diagnosis, or on ﬁndings from
brain imaging (eg, CT or MRI of the head). For clarity
and to exclude more distinct populations, we will
include only patients experiencing a TIA or ‘minor’
stroke. ‘Minor’ stroke will be deﬁned by a score of three
or less on the National Institutes of Health stroke scale
at initial assessment as per previous authors25 or a modi-
ﬁed Rankin scale of two or less. We will exclude moder-
ate or severe patients with stroke. No restrictions will be
made based on gender.
Types of interventions
The WHO has deﬁned rehabilitation as:
a set of measures that assist individuals who experience,
or are likely to experience, disability to achieve and main-
tain optimal functioning in interaction with their
environments26.
Any rehabilitation programme or intervention aimed
at tackling secondary prevention of vascular events fol-
lowing a TIA or ‘minor’ stroke will be eligible for inclu-
sion, for example, educational programmes, aerobic or
exercise classes, self-management and lifestyle interven-
tions. The review will include any 1:1 or group-based
intervention, hospital-based, outpatient-based or home-
based programmes. We will include trials with a com-
parative control group and trials with multiple interven-
tion arms (comparing different types of rehabilitation
interventions). The review will not include population
or community-wide interventions (eg, mass media cam-
paigns, built environment).
Types of outcome measures
Primary outcomes
▸ Quantitative between-group differences for blood
pressure, lipid proﬁle (total cholesterol, high-density
lipoprotein, low-density lipoprotein, triglycerides),
glycaemic control in diabetes mellitus glycated hemo-
globin, body mass index (BMI) or validated cardiovas-
cular risk score.
▸ Any indicator of patient adherence to secondary pre-
vention medications, for example, self-reported medi-
cation adherence or medication persistence,
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medication possession, individual patient data on pre-
scriptions, pharmacy claims, electronic monitoring
and drug tracers in the blood or urine.
Secondary outcomes
▸ Secondary cardiovascular events: stroke, myocardial
infarction or vascular death.
Search methods for identification of studies
To identify studies for inclusion in this review, detailed
search strategies will be developed for each electronic
database searched with input from a medical librarian.
These will be based on the search strategy developed for
Medical Literature Analysis and Retrieval System Online
(MEDLINE) (see online supplementary additional ﬁle 1)
but revised appropriately for each database.
Electronic searches
We will search the Cochrane Central Register of
Controlled Trials (CENTRAL) in the Cochrane Library,
the Cochrane Database of Systematic Reviews (CDSR) in
the Cochrane Library to December 2014, Ovid
MEDLINE(R) Daily Update, Ovid MEDLINE(R) 1946 to
December 2014, Ovid MEDLINE—includes new records
not yet fully indexed, Ovid Embase 1974 to December
2014, EBSCO Cumulative Index to Nursing and Allied
Health Literature (CINAHL) plus 1937 to December
2014 and Ovid PsycINFO 1806 to December 2014.
Indexed versions of Medline will be combined with
the Cochrane Search Strategy for identifying rando-
mised trials in MEDLINE: sensitivity-maximising and
precision-maximising version (2008 revision).
CINAHL and Embase searches will be combined with
the SIGN search ﬁlters developed to retrieve rando-
mised controlled trials in these databases.
Any systematic reviews of rehabilitation interventions in
the acute period following a TIA or ‘minor’ stroke will be
screened for additional references. Additional studies will
be identiﬁed from the reference lists of the retrieved
papers. The reviewers will supplement the electronic search
strategy by using the Science Citation Index to perform cit-
ation tracking of the trials identiﬁed by the ﬁrst step.
Study inclusion and exclusion criteria
The inclusion criteria are:
▸ Adults aged 18 years old or above who have been
diagnosed with a TIA and/or ‘minor’ stroke.
▸ Assesses the impact of a rehabilitation programme
initiated within 90 days of the diagnosis of a TIA or
‘minor’ stroke.
▸ The outcome measure for the study includes a car-
diovascular risk factor (eg, blood pressure, physical
activity levels), cardiovascular outcome (eg, further
stroke event) and/or death.
▸ The study is a randomised controlled trial or
quasi-randomised controlled trial.
The exclusion criteria are:
▸ Includes moderate and/or severe stroke subtypes.
▸ No rehabilitation service evaluated.
▸ No modiﬁable CVD risk factors, cardiovascular events
and/or death outcomes reported.
▸ Protocol paper and therefore no results available.
Data collection and analysis
Selection of studies
Results from the searches will be imported into
EndNote (X7) bibliographic software (Thomson
Reuters, Philadelphia, Pennsylvania, USA) and dupli-
cates removed. The titles and abstracts of publications
obtained by the search strategy will be independently
screened by two authors (NH 100%, MEC 100%).
Articles that do not meet the inclusion criteria will be
removed. All remaining publications will be retrieved for
further assessment. Based on the information within the
full reports, two review authors (NH, MEC) will use a
standardised form tested prior to use to select the trials
eligible for inclusion in the review, if necessary, a third
review author (FK) will resolve disagreements. A record
will be kept of all articles excluded at this stage and the
reason for their exclusion.
No language restrictions will be made; non-English
papers will be assessed and, if necessary, translated with
the assistance of a native speaker.
Data extraction and management
Data will be extracted independently by two review
authors (NH, MEC) using a customised form, piloted
prior to use. This will be used to extract relevant data on
methodological issues, eligibility criteria, interventions
(including the number of participants treated, interven-
tion provider) and study design, study duration,
follow-up, comparisons, outcome measures, results, with-
drawals and adverse events. The κ and percentage dis-
agreement will be calculated, the two reviewers will meet
to resolve any discrepancies, with third party adjudica-
tion if required.
In the case of multiple publications of the same study,
the team will, where possible, extract and combine all of
the available data, in case of doubt; the original publica-
tion will be given priority. Where data seem to be
missing from a study this will, if possible, be obtained
through correspondence with the study authors. A table
showing the characteristics of the included and excluded
studies will be created.
There will be no blinding to study author, institution
or journal. Two authors will independently select studies
for inclusion based on the following criteria. The study:
1. Restricted participants to TIA or ‘minor’ stroke
patients, or reported outcomes separately for TIA or
‘minor’ stroke patient subgroups;
2. Evaluated a rehabilitation service intervention;
3. Stated or clearly implied that the intention of an
intervention was to improve modiﬁable risk factor
control and/or function;
4. Assessed one or more of the deﬁned outcome
measures.
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The review team will resolve any disagreements regarding
study eligibility by discussion between all review authors.
A record will be kept of the following information for
each study:
1. General information: published or unpublished, title,
authors, journal or source, publication date, country
of origin, publication language.
2. Study methods: unit of randomisation (and method),
allocation concealment (and method), blinding
(outcome assessors), validation of questionnaires.
3. Participants: sampling (random or convenience), place
of recruitment, total sample size, numbers randomised,
inclusion criteria, exclusion criteria, demographic
characteristics (age, gender, ethnicity, socioeconomic or
sociodemographic status), disability (modiﬁed Rankin
score, Barthel score), comorbidities, similarity between
groups at baseline, dropout and withdrawal rates.
4. Intervention details: components, length, frequency,
location, mode of delivery, personnel responsible for
delivery, timing post-stroke, details of control protocol.
5. Outcomes: prespeciﬁed outcomes deﬁned above,
follow-up intervals from start of intervention, units of
measurement, missing data.
6. Results: results for prespeciﬁed outcomes, number of
participants assessed, method of analysis
(intention-to-treat analysis, per protocol analysis).
7. Intervention category: prespeciﬁed in the review
protocol.
Assessment of risk of bias
Two review authors (NH, MEC) will independently
assess each included study for risk of bias using the risk
of bias tool, following guidance from the Cochrane
Handbook of Systematic Reviews of Interventions.27 The
following domains will be considered:
▸ Was the allocation sequence adequately generated?
▸ Was the allocation adequately concealed?
▸ Was knowledge of the allocated intervention adequately
prevented during the study?
▸ Were incomplete outcome data adequately
addressed?
▸ Are reports of the study free of suggestion of selective
outcome reporting?
▸ Was the study apparently free of other problems that
could put it at a high risk of bias?
To minimise bias in interpretation of the tool, a small
sample of unrelated studies will be assessed.
Inconsistency in scoring will be reviewed, and a consen-
sus reached prior to the analysis of the review studies.
The tool will be used to judge and report whether a trial
is deemed to be at ‘high’, ‘low’ or ‘uncertain’ risk of
bias. A summary statement regarding the quality of the
data included in the review and a narrative account of
any serious ﬂaws will be reported.
External validity
To ensure the results of the systematic review and
meta-analysis are generalisable to the true study
population of interest (those with a TIA and’or ‘minor’
stroke diagnosis) we will consider the external validity of
all included studies. To do this we will report on relevant
aspects of the included studies in the review,28
including:
▸ Participant characteristics with reference to the back-
ground population (age, gender, source of
recruitment);
▸ Sample size;
▸ Type and characteristics of the rehabilitation
intervention.
This will allow us to comment on how representative
the included studies are of the intended true population
and therefore allow clinicians to better apply the evi-
dence to their study population of interest.
Measures of treatment effect
For each study, relative risk and 95% CIs will be calcu-
lated for dichotomous outcomes, and mean differences
and 95% CIs will be calculated for continuous out-
comes. Where continuous outcomes are pooled on dif-
ferent scales, standardised mean differences will be
used. Where available, changes from baseline (mean
change scores) will be used in preference to follow-up
scores.
Unit of analysis issues
The review team anticipates two possible units of analysis
issues that may arise; repeated observations of the same
outcome and studies including multiple intervention
arms.
If studies report multiple observations of the same
outcome, the reviewers will extract data at the following
time points: baseline, short-term (not longer than
12 weeks post-randomisation), medium-term (not longer
than 6 months postrandomisation), and long-term
(greater than 6 months postrandomisation) follow-up.
In the case of studies including multiple intervention
groups, the reviewers will follow the recommended
method suggested by the Cochrane Collaboration
section 16.527 for combining multiple groups from one
study. For continuous outcomes, means and SDs will be
combined using methods and formulae described in
chapter 7 (7.7.3.8)—combining groups, in the Cochrane
Handbook of Systematic Reviews of Interventions.27
The following will be considered in relation to asses-
sing the risk of bias in multiple intervention studies:
▸ Are data presented for each of the groups to which
participants were randomised?
▸ Are reports of the study free of suggestion of selective
reporting of comparisons of intervention arms for
some outcomes?
Missing data
Attempts will be made where necessary to contact ori-
ginal investigators to request missing data. If SDs are
missing from continuous data, studies will be scanned
for other statistics such as CIs, SEs or p values that would
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allow for its calculation. If there are a large number of
missing SDs, then imputation will not be carried out.
Assessing for heterogeneity
Diversity across the studies will be assessed qualitatively
in terms of intervention (content, duration, frequency,
provider and setting), participant demographics,
outcome measures and follow-up. If two or more studies
are considered clinically homogenous according to the
above terms, data will be assessed for statistical hetero-
geneity using RevMan V.5.1. The review team will use
the χ2 test in conjunction with the I2 statistic. The level
of signiﬁcance for the χ2 will be set at p<0.1. Values of I2
that are 30–60% will be considered to represent moder-
ate heterogeneity and 50–90% substantial heterogen-
eity.27 In the case of substantial heterogeneity, the review
team will pool studies using a random effects model; in
the case of low or no heterogeneity, the review team will
analyse studies using a ﬁxed effects model. A sensitivity
analysis will be performed to investigate the effect of
inclusion and exclusion of heterogeneous studies.
Assessment of reporting bias
A funnel plot will be prepared if there are sufﬁcient
studies by plotting trial effect against SE. The plot will
be inspected for asymmetry to investigate reporting bias.
Data synthesis
In complex healthcare interventions, effects can be
modiﬁed by a wide variety of factors and we anticipate a
high degree of heterogeneity within the included
studies. Careful consideration will be given to the appro-
priateness of conducting a meta-analysis. Data will be
summarised statistically when the data are available, suf-
ﬁciently similar and of sufﬁcient quality. The statistical
analysis will be performed in accordance with the statis-
tical guidelines referenced in V.5.1.0 of the Cochrane
Handbook for Systematic Reviews of Interventions.27
A narrative synthesis will be completed if there is insuf-
ﬁcient data to permit a formal meta-analysis. The narra-
tive synthesis will attempt to summarise the current state
of knowledge, describe the interventions, study designs
and the robustness of the evidence.
Subgroup analysis and investigation of heterogeneity
Outcome assessment data for all time periods where
available will be grouped into three time periods for the
purposes of analysis: baseline (0–3 months), medium-
term (3–6 months), and long-term follow-up (greater
than 6 months).
Where possible, the following subgroup analysis will
be performed:
▸ Duration and/or frequency of intervention (previous
reviews have noted correlations between effect and
duration of interventions).
▸ Recruitment setting—that is, primary or secondary
care
▸ Initial clinical conditions (TIA or ‘minor’ stroke).
▸ Whether the intervention is hospital-based, community-
based or home-based.
Sensitivity analysis
A sensitivity analysis may be performed to check if
including or excluding studies of lower methodological
rigour or higher risk of bias affects the comparison
between groups. If sensitivity analysis appears to inﬂu-
ence the ﬁndings of the review, this will be reported in
the ‘Discussion’ section.
DISCUSSION
Rehabilitation programmes following an initial diagnosis
of a TIA or ‘minor’ stroke have the potential to address
the increased risk of morbidity and mortality in this
population. Reviews identifying effective components of
rehabilitation following the diagnosis of a stroke have
begun to emerge,23 24 but to date, this will be the ﬁrst
systematic review to review the use of rehabilitation pro-
grammes in the acute period (within 90 days) of the
diagnosis of a TIA or ‘minor’ stroke. The ﬁndings of this
review may be applied in clinical and rehabilitation set-
tings but will also be of value to those involved in design-
ing and developing complex healthcare interventions.
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